A more affordable drug for neuroendocrine tumors diagnostics passing preclinical tests

(Tomsk Polytechnic University) Radiopharmaceuticals developed at Tomsk Polytechnic University will make the diagnostics of rare neuroendocrine tumors and prostate cancer more affordable thanks to the replacement of pricey radionuclides with reasonable technetium.

Comments